![]() |
|
|
Vol. 62, Issue 2, 297-303, August 2002
Immunoscience Department, Pharmaceutical Discovery Division, Abbott
Laboratories, Abbott Park, Illinois (C.W.L., M.N., M.S., D.F., J.K.,
L. M., R.H., P.K., G.C., B.C.L.); Ligand Pharmaceuticals, San
Diego, California (C.T., J.N.M., J.R.); and Eli Lilly and Co., Lilly
Corporate Center, Indianapolis, Indiana (M.J.C.)
Glucocorticoids are potent anti-inflammatory and immunosuppressant
agents. However, they also produce serious side effects that limit
their usage. It has been proposed that anti-inflammatory properties of
glucocorticoids are caused mostly by repression of activator protein 1- and nuclear factor 
-stimulated synthesis of inflammatory
mediators, whereas most of their adverse effects are associated with
trans-activation of genes involved with metabolic processes. Our laboratories have sought to discover novel
glucocorticoid receptor (GR) ligands that have high repression but low
trans-activation activities. We describe here cellular
properties of
2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and its four enantiomers. Similar to dexamethasone, A276575
exhibited high affinity for GR and potently repressed interleukin (IL)
1
-stimulated IL-6 production in human skin fibroblasts, prostaglandin (PG) E2 production in A549 human lung
epithelial cells, and concanavalin A-induced monocyte proliferation. In
contrast to dexamethasone, A276575 caused smaller induction of
aromatase activity in human skin fibroblasts and antagonized
dexamethasone-induced activation of an mouse mammary tumor
virus-glucocorticoid-response element (GRE) reporter gene construct.
Among the four enantiomers of A276575, the two (
)-enantiomers showed
10- to 30-fold higher affinities for GR than their respective
(+)-enantiomers. Both (
)-Syn and (
)-Anti enantiomers of A276575
were potent inhibitors of IL-1
-stimulated PGE2 production in A549
lung epithelial cells; unexpectedly, however, only the (
)-Anti
enantiomer inhibited regulated on T-cell activation, normal T-cell
expressed and secreted (RANTES) production in A549 cells. In summary,
A276575 is a novel, nonsteroidal GR ligand that possesses high
repression activities against inflammatory mediator production but has
lower GRE trans-activation activities than traditional
steroids. Differential repression of RANTES and PGE2 production in a
cell by the two (
)-enantiomers of A276575 illustrates the complexity
of repression by GR.
This article has been cited by other articles:
![]() |
F. J. Lopez, R. J. Ardecky, B. Bebo, K. Benbatoul, L. De Grandpre, S. Liu, M. D. Leibowitz, K. Marschke, J. Rosen, D. Rungta, et al. LGD-5552, an Antiinflammatory Glucocorticoid Receptor Ligand with Reduced Side Effects, in Vivo Endocrinology, May 1, 2008; 149(5): 2080 - 2089. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Miner, B. Ardecky, K. Benbatoul, K. Griffiths, C. J. Larson, D. E. Mais, K. Marschke, J. Rosen, E. Vajda, L. Zhi, et al. Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein protein interaction profile PNAS, December 4, 2007; 104(49): 19244 - 19249. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Kim, G.-S. Lee, Y.-K. Ji, K.-C. Choi, and E.-B. Jeung Differential expression of uterine calcium transporter 1 and plasma membrane Ca2+ ATPase 1b during rat estrous cycle. Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E234 - E241. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hochhaus New Developments in Corticosteroids Proceedings of the ATS, November 1, 2004; 1(3): 269 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. De Bosscher, W. Vanden Berghe, and G. Haegeman The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression Endocr. Rev., August 1, 2003; 24(4): 488 - 522. [Abstract] [Full Text] [PDF] |
||||